Stay updated on IGN002 Dose-Escalation Study in NHL Clinical Trial
Sign up to get notified when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.

Latest updates to the IGN002 Dose-Escalation Study in NHL Clinical Trial page
- Check2 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's version. This change reflects metadata, not new study content or user-facing features.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThis updates the ClinicalTrials.gov page viewer/version label from **v3.5.2** to **v3.5.3**, reflecting a site or template revision without changing the underlying study information.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.1%

- Check60 days agoChange DetectedFooter shows an updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check74 days agoChange DetectedThe page shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page shows a minor version update from v3.4.1 to v3.4.2 with no changes to study content or visible functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IGN002 Dose-Escalation Study in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGN002 Dose-Escalation Study in NHL Clinical Trial page.